Correlation Between XSpray Pharma and Xbrane Biopharma
Can any of the company-specific risk be diversified away by investing in both XSpray Pharma and Xbrane Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining XSpray Pharma and Xbrane Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between XSpray Pharma AB and Xbrane Biopharma AB, you can compare the effects of market volatilities on XSpray Pharma and Xbrane Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in XSpray Pharma with a short position of Xbrane Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of XSpray Pharma and Xbrane Biopharma.
Diversification Opportunities for XSpray Pharma and Xbrane Biopharma
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between XSpray and Xbrane is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding XSpray Pharma AB and Xbrane Biopharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xbrane Biopharma and XSpray Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on XSpray Pharma AB are associated (or correlated) with Xbrane Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xbrane Biopharma has no effect on the direction of XSpray Pharma i.e., XSpray Pharma and Xbrane Biopharma go up and down completely randomly.
Pair Corralation between XSpray Pharma and Xbrane Biopharma
Assuming the 90 days trading horizon XSpray Pharma AB is expected to generate 0.23 times more return on investment than Xbrane Biopharma. However, XSpray Pharma AB is 4.28 times less risky than Xbrane Biopharma. It trades about 0.03 of its potential returns per unit of risk. Xbrane Biopharma AB is currently generating about 0.0 per unit of risk. If you would invest 3,770 in XSpray Pharma AB on August 29, 2024 and sell it today you would earn a total of 425.00 from holding XSpray Pharma AB or generate 11.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
XSpray Pharma AB vs. Xbrane Biopharma AB
Performance |
| Timeline |
| XSpray Pharma AB |
| Xbrane Biopharma |
XSpray Pharma and Xbrane Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with XSpray Pharma and Xbrane Biopharma
The main advantage of trading using opposite XSpray Pharma and Xbrane Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if XSpray Pharma position performs unexpectedly, Xbrane Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xbrane Biopharma will offset losses from the drop in Xbrane Biopharma's long position.| XSpray Pharma vs. Xbrane Biopharma AB | XSpray Pharma vs. Hansa Biopharma AB | XSpray Pharma vs. Cantargia AB | XSpray Pharma vs. Vicore Pharma Holding |
| Xbrane Biopharma vs. Hansa Biopharma AB | Xbrane Biopharma vs. Vicore Pharma Holding | Xbrane Biopharma vs. XSpray Pharma AB | Xbrane Biopharma vs. Saniona AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |